BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 36739918)

  • 1. Development and Validation of a Normal Tissue Complication Probability Model for Lymphedema After Radiation Therapy in Breast Cancer.
    Park YI; Chang JS; Ko H; Im SH; Kim JS; Byun HK; Kim YB; Jung W; Kim K; Hong CS
    Int J Radiat Oncol Biol Phys; 2023 Aug; 116(5):1218-1225. PubMed ID: 36739918
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determining the Organ at Risk for Lymphedema After Regional Nodal Irradiation in Breast Cancer.
    Gross JP; Lynch CM; Flores AM; Jordan SW; Helenowski IB; Gopalakrishnan M; Cutright D; Donnelly ED; Strauss JB
    Int J Radiat Oncol Biol Phys; 2019 Nov; 105(3):649-658. PubMed ID: 31260718
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incorporating axillary-lateral thoracic vessel juncture dosimetric variables improves model for predicting lymphedema in patients with breast cancer: A validation analysis.
    Suk Chang J; Ko H; Hee Im S; Sung Kim J; Kyung Byun H; Bae Kim Y; Jung W; Park G; Sun Lee H; Sung W; Olson R; Hong CS; Kim K
    Clin Transl Radiat Oncol; 2023 Jul; 41():100629. PubMed ID: 37131951
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Axillary Lateral Vessel Thoracic Junction Is Not an Organ at Risk for Breast Cancer-Related Lymphedema.
    Healy E; Beyer S; Jhawar S; White JR; Bazan JG
    Int J Radiat Oncol Biol Phys; 2023 Oct; 117(2):452-460. PubMed ID: 37059233
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential for reduced toxicity and dose escalation in the treatment of inoperable non-small-cell lung cancer: a comparison of intensity-modulated radiation therapy (IMRT), 3D conformal radiation, and elective nodal irradiation.
    Grills IS; Yan D; Martinez AA; Vicini FA; Wong JW; Kestin LL
    Int J Radiat Oncol Biol Phys; 2003 Nov; 57(3):875-90. PubMed ID: 14529795
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of a mixed beam therapy for postmastectomy breast cancer patients: Bolus electron conformal therapy combined with intensity modulated photon radiotherapy and volumetric modulated photon arc therapy.
    Zhang R; Heins D; Sanders M; Guo B; Hogstrom K
    Med Phys; 2018 Jul; 45(7):2912-2924. PubMed ID: 29749075
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A multivariable normal tissue complication probability model for predicting radiation-induced hypothyroidism in nasopharyngeal carcinoma patients in the modern radiotherapy era.
    Wongwattananard S; Prayongrat A; Srimaneekarn N; Hayter A; Sophonphan J; Kiatsupaibul S; Veerabulyarith P; Rakvongthai Y; Ritlumlert N; Kitpanit S; Kannarunimit D; Lertbutsayanukul C; Chakkabat C
    J Radiat Res; 2024 Jan; 65(1):119-126. PubMed ID: 37996086
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Normal tissue complication probability models of hypothyroidism after radiotherapy for breast cancer.
    Park YI; Cho MS; Chang JS; Kim JS; Kim YB; Lee IJ; Hong CS; Choi SH
    Clin Transl Radiat Oncol; 2024 Mar; 45():100734. PubMed ID: 38317677
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictive modelling for late rectal and urinary toxicities after prostate radiotherapy using planned and delivered dose.
    Ong ALK; Knight K; Panettieri V; Dimmock M; Tuan JKL; Tan HQ; Wright C
    Front Oncol; 2022; 12():1084311. PubMed ID: 36591496
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prediction of gastrointestinal toxicity after external beam radiotherapy for localized prostate cancer.
    D'Avino V; Palma G; Liuzzi R; Conson M; Doria F; Salvatore M; Pacelli R; Cella L
    Radiat Oncol; 2015 Apr; 10():80. PubMed ID: 25890376
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dosimetric Evaluation of Incorporating Patient Geometric Variations Into Adaptive Plan Optimization Through Probabilistic Treatment Planning in Head and Neck Cancers.
    Liu Q; Liang J; Zhou D; Krauss DJ; Chen PY; Yan D
    Int J Radiat Oncol Biol Phys; 2018 Jul; 101(4):985-997. PubMed ID: 29976511
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NTCP model for hypothyroidism after supraclavicular-directed radiation therapy for breast cancer.
    Huang H; Roberson J; Hou W; Mani K; Valentine E; Ryu S; Stessin A
    Radiother Oncol; 2021 Jan; 154():87-92. PubMed ID: 32926911
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lyman-Kutcher-Burman normal tissue complication probability modeling for radiation-induced esophagitis in non-small cell lung cancer patients receiving proton radiotherapy.
    Wang Z; Chen M; Sun J; Jiang S; Wang L; Wang X; Sahoo N; Gunn GB; Frank SJ; Nguyen QN; Liao Z; Chang JY; Zhu XR; Zhang X
    Radiother Oncol; 2020 May; 146():200-204. PubMed ID: 32220701
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Normal Tissue Complication Probability (NTCP) modeling of late rectal bleeding following external beam radiotherapy for prostate cancer: A Test of the QUANTEC-recommended NTCP model.
    Liu M; Moiseenko V; Agranovich A; Karvat A; Kwan W; Saleh ZH; Apte AA; Deasy JO
    Acta Oncol; 2010 Oct; 49(7):1040-4. PubMed ID: 20831493
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of the confidence interval in the multivariable normal tissue complication probability model for predicting radiation-induced liver disease in primary liver cancer.
    Prayongrat A; Srimaneekarn N; Sriswasdi S; Ito YM; Katoh N; Tamura M; Dekura Y; Toramatsu C; Khorprasert C; Amornwichet N; Alisanant P; Hirata Y; Hayter A; Shirato H; Shimizu S; Kobashi K
    J Radiat Res; 2021 May; 62(3):483-493. PubMed ID: 33899102
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NTCP Models for Severe Radiation Induced Dermatitis After IMRT or Proton Therapy for Thoracic Cancer Patients.
    Palma G; Monti S; Conson M; Xu T; Hahn S; Durante M; Mohan R; Liao Z; Cella L
    Front Oncol; 2020; 10():344. PubMed ID: 32257950
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of a normal tissue complication probability model for late unfavourable aesthetic outcome after breast-conserving therapy.
    Kindts I; Defraene G; Laenen A; Petillion S; Van Limbergen E; Depuydt T; Weltens C
    Acta Oncol; 2018 Jul; 57(7):916-923. PubMed ID: 29652212
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Normal tissue complication probability modeling for acute esophagitis in patients treated with conformal radiation therapy for non-small cell lung cancer.
    Chapet O; Kong FM; Lee JS; Hayman JA; Ten Haken RK
    Radiother Oncol; 2005 Nov; 77(2):176-81. PubMed ID: 16256230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypofractionated irradiation of infra-supraclavicular lymph nodes after axillary dissection in patients with breast cancer post-conservative surgery: impact on late toxicity.
    Guenzi M; Blandino G; Vidili MG; Aloi D; Configliacco E; Verzanini E; Tornari E; Cavagnetto F; Corvò R
    Radiat Oncol; 2015 Aug; 10():177. PubMed ID: 26289040
    [TBL] [Abstract][Full Text] [Related]  

  • 20. External validation of an NTCP model for acute esophageal toxicity in locally advanced NSCLC patients treated with intensity-modulated (chemo-)radiotherapy.
    Dankers FJWM; Wijsman R; Troost EGC; Tissing-Tan CJA; Kwint MH; Belderbos J; de Ruysscher D; Hendriks LE; de Geus-Oei LF; Rodwell L; Dekker A; Monshouwer R; Hoffmann AL; Bussink J
    Radiother Oncol; 2018 Nov; 129(2):249-256. PubMed ID: 30241789
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.